Aspen Neuroscience Shares Promising Results from ASPIRO Phase 1/2a Clinical Trial of Parkinson's Cell Therapy Aspen Neuroscience reveals significant findings from the ASPIRO trial, exploring a groundbreaking cell therapy aimed at treating Parkinson's disease effectively.

Aspen Neuroscience Shares Promising Results from ASPIRO Phase 1/2a Clinical Trial of Parkinson's Cell Therapy #USA #San_Diego #ANPD001 #Parkinsons_Disease #ASPIRO_Trial